SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2012 / Cilt: 21 - Sayı: 1

Diskoid lupus eritamatozus olgusunda kulaklarda olağan dışı artmış F-18 FDG tutulumu

Unusual F-18 FDG uptake at the ears of a patient with discoid lupus erythematosus

TAMER ÖZÜLKER
Filiz ÖZÜLKER
Filiz CEBECİ
Adnan SOMAY
Mehmet Tarık TATOĞLU
Tevfik ÖZPAÇACI
Pages
29–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Histopathological examination of the biopsy specimen obtained from the ears revealed discoid lupus erythematosus (DLE).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 55-year-old patient, who had undergone excisional biopsy of upper lip two years ago and diagnosed to have squamous cell carcinoma, was referred to us for evaluation with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET)/CT (F-18 FDG-PET/CT) scan.
📊
Key Findings & Data:F-18 FDG-PET/CT scan was performed and the maximum intensity projection images (MIP) showed unusual FDG uptake at both ears.
💡
Conclusion & Impact:Histopathological examination of the biopsy specimen obtained from the ears revealed discoid lupus erythematosus (DLE).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 55-year-old patient, who had undergone excisional biopsy of upper lip two years ago and diagnosed to have squamous cell carcinoma, was referred to us for evaluation with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET)/CT (F-18 FDG-PET/CT) scan. F-18 FDG-PET/CT scan was performed and the maximum intensity projection images (MIP) showed unusual FDG uptake at both ears. Histopathological examination of the biopsy specimen obtained from the ears revealed discoid lupus erythematosus (DLE).

Özet

İki yıl önce üst dudaktan eksizyonel biyopsi yapılarak skuamöz hücreli karsinom tanısı alan 55 yasındaki erkek hasta, Flor-18 florodeoksiglukoz (F-18 FDG) pozitron emisyon tomografisi (PET)/BT (F-18 FDG-PET/BT) tetkiki ile değerlendirilmek üzere kliniğimize sevk edilmiş. F-18 FDG-PET/BT tetkiki maksimum intensite projeksiyon görüntülerinde (MIP) her iki kulakta olağan dışı artmış FDG tutulumu izlendi. Kulaktan alınan biyopsi numunesinin patolojik incelemesinde diskoid lupus eritematozus (DLE) tanısı elde edildi.

🔖

Cite This Article

ÖZÜLKER, T., ÖZÜLKER, F., CEBECİ, F., SOMAY, A., TATOĞLU, M. T., ÖZPAÇACI, T. (2012). Diskoid lupus eritamatozus olgusunda kulaklarda olağan dışı artmış F-18 FDG tutulumu. Molecular Imaging and Radionuclide Therapy, Cilt: 21 - Sayı: 1, 29–31. https://ajindex.com/articles/295274

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-68
  2. Meyer GJ, Schober O, Stoppe G, Wildhagen K, Seidel JW, Hundeshagen H. Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods. Psychiatry Res 1989;29:367-368
  3. Stoppe G, Wildhagen K, Seidel JW, Meyer GJ, Schober O, Heintz P Künkel H, Deicher H, Hundeshagen H. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990;40:304-308
  4. Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E, Gutfleisch J, Hoegerle S, Juengling FD, Nitzsche EU. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 1997;24:787-791
  5. Grunwald F Schomburg A, Badali A, Ruhlmann J, Pavics L, Biersack HJ. 18FDG PET and acetazolamide-enhanced 99mTc- HMPAO SPET in systemic lupus erythematosus. Eur J Nucl Med 1995;22:1073-1077
  6. Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P Nitzsche EU, Moser E, Peter HH. Diagnosis and moni- toring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000;59:377-385
  7. Stimmler MM, Coletti PM, Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythe- matosus. Semin Arthritis Rheum 1993;22:335-349
  8. West SG, EmlenW,Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diag- nostic tests. Am J Med 1995;99:153-163
  9. Kozora E,West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41-47
  10. Otte A, Weiner SM, Hoegerle S, Wolf R, Juengling FD, Peter HH, Nitzsche EU. Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 1998;7:57-59
  11. Stoppe G, Wildhagen K, Meyer GJ, Schober O. Use of fluo- rodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI. Nuklearmedizin 1989;28:187-192
  12. Callen JP Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad D